Found 28 matching trials
REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases PHASE4 The goal of this clinical trial is to assess the effectiveness of a disease...
Show More Location
Sint Maartenskliniek Nijmegen
Learn More & Join Trial
Safety and Tolerability Study of Mivebresib Tablet Alone or in Combination With Ruxolitinib Tablet or Navitoclax Tablet in Adult Participants With Myelofibrosis PHASE1 Myelofibrosis (MF) is a bone marrow illness that affects blood-forming tiss...
Show More Location
Stony Brook University Hospital /ID# 222653
Learn More & Join Trial
Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis PHASE2 This study evaluates TL-895, a potent, orally-available and highly selectiv...
Show More Location
University of Colorado - Aurora Cancer Center
Learn More & Join Trial
Flonoltinib Maleate Oral Regimens in Patients With Myelofibrosis PHASE2 The goal of this clinical trial is to learn which of three different doses ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Single-Arm, Phase Ⅰb Study of Golidocitinib Combined With Anti-PD-1 for the Treatment of Previously Treated NSCLC PHASE1 This study is a phase Ib, single-center, single-arm exploratory clinical st...
Show More Location
241, West Huaihai Road, Shanghai, Shanghai, Shanghai 200030
Learn More & Join Trial
A Clinical Study of Gecacitinib Combined With Pegylated Interferon in Patients With PV NA The goal of this clinical trial is to evaluate the efficacy and safety of G...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
Tofacitinib in the Treatment of Refractory Axial Spondyloarthritis Patients: A Dose Escalation Study PHASE4 The goal of this clinical trial is to assess the efficacy of tofacitinib in...
Show More Location
Bangabandhu Sheikh Mujib Medical University
Learn More & Join Trial
Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis PHASE2 The purpose of this Phase 2 study is to evaluate the efficacy and safety of...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2) PHASE3 A Phase 3, randomized, blinded study comparing pelabresib (CPI-0610) and ru...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Learn More & Join Trial
A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies PHASE1 Phase 1 Part: This was an open-label, sequential dose escalation study of p...
Show More Location
Mayo Clinic Arizona
Learn More & Join Trial